| Target Price | $423.30 |
| Price | $380.32 |
| Potential |
11.30%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Humana 2027 .
The average Humana target price is $423.30.
This is
11.30%
register free of charge
$538.65
41.63%
register free of charge
$282.80
25.64%
register free of charge
|
|
| A rating was issued by 33 analysts: 16 Analysts recommend Humana to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Humana stock has an average upside potential 2027 of
11.30%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 129.66 | 164.23 |
| 10.11% | 26.66% | |
| EBITDA Margin | 3.17% | 1.71% |
| 3.99% | 45.97% | |
| Net Margin | 0.92% | 0.68% |
| 10.61% | 25.78% |
27 Analysts have issued a sales forecast Humana 2026 . The average Humana sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Humana EBITDA forecast 2026. The average Humana EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Humana Analysts have issued a net profit forecast 2026. The average Humana net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 9.83 | 9.24 |
| 1.60% | 6.00% | |
| P/E | 41.15 | |
| EV/Sales | 0.32 |
30 Analysts have issued a Humana forecast for earnings per share. The average Humana EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Raymond James |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Jul 30 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


